Articles/ Views and analysis Patient perspectives: Lindsey Miller Catherine 0 Comment Rebecca Aris interviews pancreatic neuroendocrine cancer patient Lindsey Miller on what it’s like to live with the disease Share X Patient perspectives: Lindsey Miller https://pharmaphorum.com/views-and-analysis/patient-perspective-lindsey-miller/
Articles/ Views and analysis Cell line authentication: helping create a strong foundation for biopharmaceutical research Catherine 0 Comment With the proliferation of studies in the fast growing fields of personalized and regenerative medicine, it is essential Share X Cell line authentication: helping create a strong foundation for biopharmaceutical research https://pharmaphorum.com/views-and-analysis/cell-line-authentication-helping-create-a-strong-foundation-for-biopharmaceutical-research/
Articles/ Views and analysis Why the iPad Matters for Healthcare Industry Catherine 0 Comment Ashish Khera takes a look into the rise of the iPad in pharmaceutical and healthcare sales and marketing. Share X Why the iPad Matters for Healthcare Industry https://pharmaphorum.com/views-and-analysis/why-the-ipad-matters-for-healthcare-industry/
Articles/ Views and analysis How NGS is changing the future of IVF Catherine 0 Comment pharmaphorum interviewed the University of Oxford’s Dr Dagan Wells following his recent acknowledgement for his work in using Share X How NGS is changing the future of IVF https://pharmaphorum.com/views-and-analysis/how-ngs-is-changing-the-future-of-ivf/
Articles/ Views and analysis Spotlight on… thyroid disease: hyperthyroidism Catherine 0 Comment There are two main types of thyroid disease – in this article, Lyn Mynott explains all about hyperthyroidism, Share X Spotlight on… thyroid disease: hyperthyroidism https://pharmaphorum.com/views-and-analysis/spotlight-on-thyroid-disease-hyperthyroidism/
Articles/ Views and analysis Intellectual property issues in personalised medicine Catherine 0 Comment In our personalised medicine focus month, Katherine Bonter discusses the developments and challenges in personalised medicine relating to Share X Intellectual property issues in personalised medicine https://pharmaphorum.com/views-and-analysis/intellectual-property-issues-in-personalised-medicine/
Articles/ Views and analysis Why PM 1.0 will not create radical healthcare change prompting the need for PM 2.0 Catherine 0 Comment Peter Keeling explores the concept of personalised medicine 2.0 in our personalised medicine themed month. The six forces Share X Why PM 1.0 will not create radical healthcare change prompting the need for PM 2.0 https://pharmaphorum.com/views-and-analysis/why-pm-1-0-will-not-create-radical-healthcare-change-prompting-the-need-for-pm-2-0/
Articles/ Views and analysis The Art of War Games Catherine 0 Comment The industry’s transition from the commercial to the competitive lifecycle stage compels companies to adopt a totally different Share X The Art of War Games https://pharmaphorum.com/views-and-analysis/the-art-of-war-games/
Articles/ Views and analysis To what degree do you need them? Catherine 0 Comment Robin Winter-Sperry highlights the challenges in recruiting the right candidate for a role in Medical Affairs. When a Share X To what degree do you need them? https://pharmaphorum.com/views-and-analysis/to-what-degree-do-you-need-them/
